Assembly Biosciences Inc (ASMB) — Capital Reinvestment Ratio
Assembly Biosciences Inc (ASMB) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow ($73.65 Million) in capital expenditures ($71.00K). See debt-free asset ratio of Assembly Biosciences Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Assembly Biosciences Inc Capital Reinvestment Ratio (2017–2023)
This chart tracks Assembly Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. Check Assembly Biosciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Assembly Biosciences Inc (2017–2023)
Year-by-year Capital Reinvestment Ratio for Assembly Biosciences Inc from 2017 to 2023. For live market cap and broader valuation context, see Assembly Biosciences Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | $22.74 Million | $255.00K | ▼ -97.6% |
| 2017 | 0.46x | $1.86 Million | $864.56K | — |